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Introduction {#sec1}
============

Mitochondria (mt) are the powerhouse of cells as they produce most cellular ATP through respiration-linked oxidative phosphorylation. In addition to harnessing energy from food material, they participate in several essential cellular functions including the integration of metabolism; synthesis of intermediates for lipid, sterol, nucleotide, and amino acid synthesis; co-ordination of apoptotic signals; and production of signaling molecules such as reactive oxygen species ([@bib28]; [@bib50]). Another important function of mitochondria, in association with the endoplasmic reticulum (ER), is to modulate intracellular Ca^2+^ homeostasis ([@bib30]). The ER is the major reservoir of Ca^2+^ in resting cells. Shuttling Ca^2+^ from the ER to the mitochondria through the IP3 receptor calcium ion channel regulates ATP production to meet the cellular energy needs ([@bib18]).

The mitochondrial function requires constant communication with the nucleus, which is achieved by tightly orchestrated signaling networks that control both the biogenesis and function of mitochondria ([@bib33]; [@bib55]). Mitochondrial biogenesis is maintained by anterograde signals from the nucleus to the mitochondria that control the import of proteins, mtDNA maintenance, and gene expression as demanded by the energy and growth requirements of the cell. Metabolic stress due to impaired mitochondrial respiration, partial or complete mtDNA depletion, disruption of cytochrome *c* oxidase (CcO) complex, suppression of mitochondrial transcription, and hypoxia can induce mitochondria-to-nucleus stress signaling pathway, called mitochondrial retrograde signaling (MtRS) ([@bib16]; [@bib33]). Recent research has focused on signaling initiated by mitochondria under stress to play a key role in cellular function and homeostasis ([@bib54]). This could involve either physical or chemical stress, which ranges from acute to chronic. Mitochondrial stress signaling affecting nuclear gene expression brings about phenotypic changes in cell morphology, cell migration, and growth characteristics ([@bib3]), which could make a change in stochastic cellular behaviors. Different MtRS signaling mechanisms have been reported in a variety of metazoan organisms and experimental contexts. The occurrence of MtRS has been reported in mtDNA mutations, deletions, recombinations, and mitochondrial unfolded protein response (mtUPR). The importance of MtRS has been implicated in multiple diseases including cancer progression, myopathies, neurodegeneration, and other disorders ([@bib3], [@bib2]; [@bib4]; [@bib23]; [@bib26]; [@bib37]; [@bib38]).

Intracellular Ca^2+^ acts as a second messenger to regulate a wide range of cellular functions, including muscle contraction, neurotransmission, and regulation of transcription through activation of specific transcription factors ([@bib21]; [@bib22]). We and others have shown that increased \[Ca^2+^\]~c~ and activation of calcineurin (Cn) are integral components of the signaling cascade involved in MtRS ([@bib10]; [@bib31]). We also showed that partial mtDNA depletion, hypoxia, environmental toxins, and other factors that affect mitochondrial function and disrupt mitochondrial membrane potential (ΔΨ~m~) initiate Ca^2+^/Cn-dependent retrograde signaling ([@bib48]). One hallmark of this signaling is the elevation of \[Ca^2+^\]~c~, which is maintained by the ER and mitochondrial Ca^2+^ stores ([@bib47]). Indeed, this intracellular organelle communication is functionally important for cellular metabolism and cell survival ([@bib25]; [@bib27]). Even though mitochondrial affinity for Ca^2+^ is relatively low, they play a vital role in taking up Ca^2+^ and releasing it back to the cytosol to regulate signaling ([@bib30]; [@bib47]). Under conditions of impaired mitochondrial function and disruption of ΔΨm, we showed increased steady-state \[Ca^2+^\]~c~ and activation of Cn, which in turn activates *NFAT*, *CREB*, *CEBPδ*, and a unique IkBβ-dependent nuclear factor-κB pathway ([@bib12]). In addition, elevated \[Ca^2+^\]~c~ also activates many kinases such as PKC, CaMKIV ([@bib4]), JNK, and MAPK ([@bib2]; [@bib29]). Furthermore, the Ca^2+^/Cn pathway activates heterogeneous nuclear ribonuclear protein *hnRNPA2*, which acts as a transcriptional co-activator for mitochondrial stress-induced transcription factors cRel:p50, *CREB*, *CEBPδ,* and *NFAT* ([@bib34]). HnRNPA2 plays a critical role in the assembly or stability of enhanceosome complexes at promoter sequences leading to synergistic activation of \>120 stress response genes ([@bib12]; [@bib33]) and telomere maintenance ([@bib36]).

We have previously shown that partial depletion of mtDNA in C2C12 cells causes increased \[Ca^2+^\]~c~ and initiates MtRS ([@bib10]). However, the precise mechanism of altered Ca^2+^ homeostasis in cells subjected to mitochondrial stress remains unresolved. In this study, we show that partial depletion of mtDNA or disruption of the CcO complex induces RyR1 and 3 Ca^2+^ channel mRNA and protein expression. This is accompanied by a decrease in steady-state levels of FKBP12, a critical regulator of RyR Ca^2+^ channel gating. Altered FKBP12-RyR binding is known to cause intracellular Ca^2+^ leak, causing increased \[Ca^2+^\]~c~ and initiating MtRS ([@bib24]; [@bib43]). A steady transfer of Ca^2+^ from the ER to mitochondria is vital for maintaining cellular bioenergetics ([@bib32]). We present evidence that mitochondrial dysfunction impairs Ca^2+^ uniporter function and uptake of Ca^2+^, leading to increased Ca^2+^ pool in the cytosol. Furthermore, short hairpin RNA (shRNA)-mediated knockdown (KD) of *RyR1* mRNAs in cells with dysfunctional mitochondria reversed Cn activity and abrogated the signaling-associated transcription factor activation and gene expression, suggesting that overexpression of RyR Ca^2+^ channel is a critical factor in the induction and maintenance of MtRS. This study provides a unified mechanism of altered Ca^2+^ homeostasis in cells subjected to two different types of mitochondrial dysfunctional stress: mtDNA depletion and CcO4KD.

Results {#sec2}
=======

A Distinctive Agonist-Induced Ca^2+^ Release Pattern in Cells with Dysfunctional Mitochondria {#sec2.1}
---------------------------------------------------------------------------------------------

Previously, we showed that activation of Cn is an early step of MtRS in partial mtDNA-depleted C2C12 skeletal myoblasts and A549 lung carcinoma cells ([@bib3]; [@bib10]). In the present study, we determined the role of mitochondrial dysfunction-induced changes in Ca^2+^ homeostasis by using *CcO* subunit *IVi1*-silenced (CcO4KD) C2C12 cells and mtDNA depletion in HCT116 and C2C12 cells. The mtDNA contents of both C2C12 cells and HCT116 cells were reported before and also presented in [Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B. [Figure S1](#mmc1){ref-type="supplementary-material"} shows that 2′,3′-Dideoxycytidine (ddC; Millipore Sigma, D5782) or ethidium bromide treatment caused about 70%--80% reduction in mtDNA content in HCT116 and C2C12 cells by about 5--10 growth cycles. All primer information is provided in [Table S1](#mmc1){ref-type="supplementary-material"}. The CcO4KD cells show reduced CcO activity, a marked metabolic shift toward glycolysis, and morphological changes similar to the mtDNA-depleted myoblasts described before ([@bib49]).

Acetylcholine is an agonist for IP3 receptor-induced Ca^2+^ release, whereas caffeine sensitizes the RyR channel opening to induce Ca^2+^ release ([@bib46]). These two agonists were used to trace the Ip3R- and RyR-mediated Ca^2+^ release in live-cell imaging. Finally, an irreversible ER Ca^2+^-ATPase inhibitor thapsigargin was used for the depletion of the ER Ca^2+^ store. Intracellular free Ca^2+^ concentration (\[Ca^2+^\]~i~) and Ca^2+^ release properties were monitored and recorded using the fluorescent dye Fura-2-AM in individual cells. Acetylcholine (10 μM), caffeine (5 mM), and thapsigargin (2 μM) were added sequentially to control and CcO4KD C2C12 cells as shown in [Figures 1](#fig1){ref-type="fig"}A and 1B (mean values of 30 cells in triplicate for each group). Control C2C12 cells showed a robust response to acetylcholine with a higher peak at 360 ± 25 nM (\[Ca^2+^\]~c~) (mean of 3 replicates and 30 cells per replicate, p \< 0.05), compared with CcO4KD cells, which gave a peak at 166 ± 10 nM (\[Ca^2+^\]~c~). However, caffeine-stimulated sarcoplasmic reticulum (SR)-Ca^2+^ release was detected only in CcO4KD cells where the (\[Ca^2+^\]~c~) was raised up to 249 nM ± 14 (p \< 0.001) ([Figures 1](#fig1){ref-type="fig"}A and 1B). [Figure 1](#fig1){ref-type="fig"}C represents the area under the curve quantifications of Ca^2+^ response with the aforementioned agonists in control and CcO4KD C2C12 cells ([Figures 1](#fig1){ref-type="fig"}A and 1B). The acetylcholine-mediated (\[Ca^2+^\]~c~) rise and ensuing recovery were faster in control cells compared with CcO4KD cells ([Figure S2](#mmc1){ref-type="supplementary-material"}A). The response to caffeine was maximal with 5 mM as 20 mM caffeine ([Figure S2](#mmc1){ref-type="supplementary-material"}B) did not induce a significantly higher \[Ca^2+^\]~c~ rise ([Figure 1](#fig1){ref-type="fig"}B).Figure 1CcO Disruption in C2C12 Cells Alters RyR and IP3R Agonist-Induced Ca^2+^ Release(A--E) \[Ca^2+^\]~c~ measurements were carried out with control and CcO4KD cells as described in the [Transparent Methods](#mmc1){ref-type="supplementary-material"}. Traces show the average response of three identical runs (average ≤ 30 cells/run) to different agonists in all cell lines. Recorded data were further analyzed by SpectralyzerLSMDeluxe version 2009092525 software to subtract the background fluorescence before calculating the F~380/340~ ratio and finally represented as nanomolars. (A) Ca^2+^ release in control cells. (B, D, and E) Ca^2+^ release for CcO4KD cells. (C) The area under the curve of increases in \[Ca^2+^\]~c~ release in response to different agonists and inhibitors. The values (μM Ca^2+^) are mean of tracings with \>90 cells presented in (B, D, and E). Caff, caffeine; Ach, acetylcholine; Tg, thapsigargin.

ATP, another IP3-mobilizing agonist, duplicated the Ca^2+^ mobilization pattern observed for acetylcholine in both CcO4KD and control cells ([Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D). The addition of caffeine after ATP (0.1 mM) induced similar \[Ca^2+^\]~c~ patterns to that for caffeine after acetylcholine. The role of the ryanodine receptor in caffeine-mediated calcium release was confirmed in experiments showing that ryanodine (50 μM), an antagonist of RyR channels, caused a decrease in the caffeine-mediated Ca^2+^ release ([Figure 1](#fig1){ref-type="fig"}E). Similarly, depletion of the ER store by pretreatment with thapsigargin essentially eliminated the caffeine-mediated Ca^2+^ release ([Figure 1](#fig1){ref-type="fig"}D). These results show that disruption of the CcO complex alters ER Ca^2+^ release by downregulating the IP3R-dependent mechanism and upregulating the RyR-mediated pathway.

To test the similarity in response to multiple forms of mitochondrial stress, we also tested the agonist-induced Ca^2+^ release in control and mtDNA-depleted colon carcinoma HCT116 cells. [Figures 2](#fig2){ref-type="fig"}A and 2B show that the peak area of ATP-induced Ca^2+^ release is smaller in mtDNA-depleted cells compared with control cells. However, treatment with caffeine following ATP stimulation evoked a \[Ca^2+^\]~c~ response only in mtDNA-depleted HCT116 cells but not in the control cells. Pretreatment with ryanodine completely abrogated caffeine response in mtDNA-depleted cells (not shown), suggesting the role of RyR channels in the altered pattern of Ca^2+^ release. The addition of acetylcholine (10 μM) did not show Ca^2+^ release in either control or mtDNA-depleted cells, suggesting the lack of muscarinic receptors. After treatment with acetylcholine, caffeine (5 mM) induced a markedly larger Ca^2+^ release in mtDNA-depleted cells than in control cells ([Figures 2](#fig2){ref-type="fig"}C and 2D). Furthermore, the addition of thapsigargin (2 μM) caused activation of store-operated \[Ca^2+^\]~c~ rises in control and mtDNA-depleted cells ([Figures 2](#fig2){ref-type="fig"}A--2D). These results confirm that mitochondrial stress initiated by both mtDNA depletion and disruption of CcO complex sensitizes cells to RyR agonist-induced Ca^2+^ release.Figure 2Ca^2+^ Release in Response to RyR Channel and IP3R Channel Agonists in Partial mtDNA-Depleted HCT116 Cells(A--D) \[Ca^2+^\]~c~ measurements were carried out with control and mtDNA-depleted HCT116 cells as in [Figure 1](#fig1){ref-type="fig"}. Traces show the average response of three different runs (average ≤ 30 cells/run) following the addition of different agonists in all cell lines. Recorded data were further analyzed by SpectralyzerLSMDeluxe version 2009092525 software to subtract the background fluorescence before calculating the F~380/340~ ratio and finally represented as nanomolars. (A and C) Ca^2+^ release in control HCT116 cells in response to different agonists as indicated in figures. (B and D) Ca^2+^ release in response to different agonists in mtDNA-depleted HCT116 cells. Caff, caffeine; Ach, acetylcholine; Tg, thapsigargin.

Impaired Calcium Clearance by Dysfunctional Mitochondria {#sec2.2}
--------------------------------------------------------

To test more directly the mechanism of the mitochondrial dysfunction-induced increase in the cytoplasmic \[Ca^2+^\], we measured the rate of mitochondrial Ca^2+^ uptake in suspensions of saponin-permeabilized cells with Fura2-FF/FA dye. The influence of ER on Ca^2+^ clearance was negated by pretreatment with thapsigargin. Dissipation of the \[Ca^2+^\]~c~ rise caused by a Ca^2+^ bolus corroborates the ~mt~Ca^2+^ uptake. [Figures 3](#fig3){ref-type="fig"}A and 3C show the time course of a 30 μM CaCl~2~ pulse-induced mitochondrial Ca^2+^ uptake and subsequent FCCP (carbonyl cyanide 4-trifluoromethoxy phenylhydrazone) addition, which fully releases the stored mitochondrial Ca^2+^. The initial rate of Ca^2+^ clearance following the addition of CaCl~2~ in C2C12 and HCT116 cells is presented in [Figures 3](#fig3){ref-type="fig"}E and 3F. The \[Ca^2+^\]~c~ rise was cleared faster in control cells than in cells with dysfunctional mitochondria ([Figures 3](#fig3){ref-type="fig"}A, 3C, 3E, and 3F). Control C2C12 cell mitochondria removed Ca^2+^ at 0.125 nM/s, whereas the clearance was nearly 30% slower in CcO4KD cells ([Figure 3](#fig3){ref-type="fig"}E). A similar decrease in Ca^2+^ clearance rate was also seen in HCT116 cells following mtDNA depletion ([Figures 3](#fig3){ref-type="fig"}C and 3F). The ΔΨ~m~ in both CcO4KD cells and mtDNA-depleted HCT116 cells was significantly lower than in the respective control cells with normal mtDNA contents or intact CcO complex ([Figures 3](#fig3){ref-type="fig"}B and 3D). Previously, we reported respiratory complex defects and reduced ΔΨ~m~ in both CcO4KD cells ([@bib49]) and mtDNA-depleted HCT116 cells ([@bib20]). The mitochondrial respiratory chain defects in mitochondrial-associated deceased patients show reduced ΔΨ~m~ along with reduced ATP synthesis, which in turn causes altered \[Ca^2+^\]~mt~ uptake under physiological stimulations ([@bib52]). In conjunction with previous findings ([@bib20]; [@bib49]; [@bib52]), these results show that cells with mitochondrial dysfunction indeed have disrupted ΔΨ~m~ and a lower rate of mitochondrial Ca^2+^ uptake that may represent the immediate upstream event for MtRS.Figure 3Impaired Mitochondrial Ca^2+^ Clearance in CcO4KD and mtDNA-Depleted CellsRepresentative scans of \[Ca^2+^\]~c~ clearance by saponin-permeabilized cells following a 30 μM CaCl~2~ spike in the presence of thapsigargin (2 μM). Recorded data were analyzed in PTI Felix and Felix GX software.(A) Ca^2+^ clearance in control and CcO4KD C2C12 cells.(B) Tetramethylrhodamine (TMRE) fluorescence in control and CcO4KD C2C12 cells.(C) Ca^2+^ clearance in control and mtDNA-depleted HCT116 cells.(D) TMRE fluorescence in control and mtDNA-depleted HCT116 cells.(E) Rates of Ca^2+^ uptake in control and CcO4KD C2C12 cells.(F) Rates of Ca^2+^ uptake by control and mtDNA-depleted HCT116 cells. Significance was calculated by one-way ANOVA with Tukey\'s multiple-comparison test, and data are presented as a mitochondrial dysfunctional group versus control. In all experiments, error bars represent standard deviations (∗p \< 0.05, ∗∗p ≤ 0.01). Caff, caffeine; Ach, acetylcholine; FCCP, carbonyl cyanide 4-trifluoromethoxy phenylhydrazone; Tg, thapsigargin.

Activation of Cn in Response to Mitochondrial Dysfunction {#sec2.3}
---------------------------------------------------------

In addition to altered agonist-induced Ca^2+^ release by cells with dysfunctional mitochondria ([Figure 1](#fig1){ref-type="fig"}), both CcO4KD C2C12 cells and mtDNA-depleted HCT116 cells also showed elevated steady-state \[Ca^2+^\]~c~ ([Figures 4](#fig4){ref-type="fig"}A and 4C). It is seen that the basal Ca^2+^ level in CcO4KD cells increased to about 80 nM as opposed to 60 nM in control C2C12 cells ([Figure 4](#fig4){ref-type="fig"}A). Similarly, the steady-state Ca^2+^ level increased in mtDNA-depleted HCT116 cells to about 130 nM from about 60 nM in control cells ([Figure 4](#fig4){ref-type="fig"}C). Consistent with the basal Ca^2+^ increase, the Cn activity was increased nearly 3-fold in CcO4KD C2C12 cells and about 2.7-fold in mtDNA-depleted HCT116 cells ([Figures 4](#fig4){ref-type="fig"}B and 4D). This is consistent with our published reports ([@bib49]) that mRNA for the catalytic subunit of Cn (CnA) was increased by 2.5-fold in CcO4KD cells. These results show that in addition to altered agonist-induced Ca^2+^ release, cells with dysfunctional mitochondria also show markedly increased Cn activity.Figure 4Elevated Cytosolic Ca^2+^ and Cn Activity in Response to Mitochondrial Dysfunction(A and B) (A) Basal \[Ca^2+^\]~c~ levels in control and CcO4KD C2C12 cells and (B) Cn activity in control and CcO4KD C2C12 cells.(C and D) (C) Basal \[Ca^2+^\]~c~ levels in control and mtDNA-depleted HCT116 cells, and (D) Cn activity in control and mtDNA-depleted HCT116 cells. The bar diagrams represent the mean ± SEM from three independent experiments. Significance was calculated by one-way ANOVA with Tukey\'s multiple-comparison test, and data are presented as a mitochondrial dysfunctional group versus control. In all experiments error bars represent standard deviations (∗p \< 0.05, ∗∗p ≤ 0.01).

Altered Ca^2+^ Uniporter System Is Insufficient to Induce Retrograde Signaling {#sec2.4}
------------------------------------------------------------------------------

The mitochondrial uniporter complex (MCUC) is the major mitochondrial inner membrane system for the import of Ca^2+^ from the cytoplasm ([@bib6]; [@bib9]; [@bib42]; [@bib45]). To understand the reason for inefficient Ca^2+^ clearance associated with dysfunctional mitochondria in [Figure 3](#fig3){ref-type="fig"}, we assessed the levels of the three key components of the MCUC: MCU, MICU1, and EMRE (C22orf32). MCU is the main channel-forming protein for the transport of Ca^2+^; EMRE is a mandatory scaffold that is required for MCU channel conductance, whereas MICU1 is a regulatory protein that mediates Ca^2+^ gating ([@bib40]) of MCU. As seen from [Figures 5](#fig5){ref-type="fig"}A and 5B, *MCU* mRNA levels were significantly reduced in mtDNA-depleted HCT116 cells, whereas there was no change in the *MICU1* mRNA level. Surprisingly, the *EMRE* mRNA level was increased in mtDNA-depleted cells ([Figure 5](#fig5){ref-type="fig"}C). A somewhat similar pattern of expression was seen in CcO4KD C2C12 myoblasts ([Figure 5](#fig5){ref-type="fig"}D), although the level of *MICU1* was also reduced significantly. Immunoblots in [Figures 5](#fig5){ref-type="fig"}E and 5F show that MCU protein level was decreased in mtDNA-depleted HCT116 cells, whereas the EMRE level was increased. The level of MICU1 was reduced marginally ([Figure 5](#fig5){ref-type="fig"}F). In CcO4KD C2C12 cells, both the MCU and MICU1 levels were significantly lower than in control cells in terms of both protein ([Figure 5](#fig5){ref-type="fig"}G) and mRNA levels ([Figure 5](#fig5){ref-type="fig"}D). However, as in HCT116 cells, the EMRE levels were higher than in control cells. These results suggest that altered uniporter abundance might contribute to the slower rate of Ca^2+^ clearing. The levels of succinate dehydrogenase (SDHA) used as a mitochondrial loading control did not change significantly.Figure 5Altered Mitochondrial Uniporter System in mtDNA-Depleted HCT116 Cells and CcO IVi1 KD C2C12 Cells(A--C) Levels of (A) *MCU*, (B) *MICU1,* and (C) *EMRE* mRNAs in control and mtDNA-depleted HCT116 cells.(D) Quantitative mRNA analysis of *MCU, MICU1 and EMRE* in control and CcO4KD C2C12 cells.(E and F) Immunoblot analysis of MCU, MICU1, and EMRE proteins from control and mtDNA-depleted HCT116. 30 μg proteins from whole-cell extracts were used in each case. Immunoblots were developed using respective primary (1:1,000 dilution) and 1:10,000 dilutions of secondary antibodies. The blots were imaged as described in the Transparent Methods. GAPDH was used as a loading control and SDHA as mitochondrial loading control.(G) Relative protein levels of MCU, MICU1, and EMRE in control, CcO4KD, and mtDNA-depleted cells. GAPDH was used as a loading control and SDHA as mitochondrial loading control.(H) Levels of MCU mRNA in control and stable MCU-specific shRNA-expressing (MCU-KD) cells.(I, J, and K) The levels of (I) *IGF1R*, (J) *Glut4*, and (K) *RyR* (1,2, 3) mRNAs, respectively, in control and MCU-KD cells. Results represent the mean ± SEM from three separate experiments. Significance was calculated by one-way ANOVA with Tukey\'s multiple-comparison test, and data are presented as a mitochondrial dysfunctional group versus control. In all experiments error bars represent standard deviations (∗p \< 0.05, ∗∗p ≤ 0.01).

To test if the reduced *MCU* mRNA played a direct role in inducing MtRs, we generated *MCU* KD cells by stably expressing shRNA for *MCU* mRNA in C2C12 cells ([Figure 5](#fig5){ref-type="fig"}H). We performed bioenergetic profile experiments with *MCU* KD and control cells to obtain respiratory parameters such as oxygen consumption rate (OCR), the percentage of oxygen consumption devoted to ATP production as well as the amount devoted to maintain the proton (H^+^) leak (ECAR), and the maximal respiratory rate under conditions of uncoupled respiration. All the OCR and ECAR measurements were performed at 37°C under air and were recorded simultaneously in an XF-24 analyzer platform. [Figure S3](#mmc1){ref-type="supplementary-material"}A shows reduced basal as well as maximal respiration in MCU KD cells. Data were corrected by normalizing with total protein concentrations. We also calculated the ratio of ECAR/OCR as a measure of the relative magnitude of glycolysis versus oxidative phosphorylation. MCU KD cells showed elevated ECAR indicative of increased glycolysis and lactate production ([Figure S3](#mmc1){ref-type="supplementary-material"}B). We tested transcriptional patterns of MtRS-specific marker genes such as insulin like growth factor 1 receptor (*IGF1R*), glucose transporter protein 4 (*Glut4*), and ryanodine receptor 1 (*RyR1*), which respond to mitochondrial respiratory stress signaling in different cells ([@bib10], [@bib14]; [@bib35]). Results in [Figures 5](#fig5){ref-type="fig"}H-5K show that all three markers of MtRS including mRNAs for *IGF1R*, *Glut4* and *RyR1* were downregulated in MCU KD cells. Thus, MCU mRNA KD and an associated reduction in Ca^2+^ clearance alone are not sufficient to induce MtRS.

The Role of RyR Ca^2+^ Channels in Increased \[Ca^2+^\]~c~ and Activation of MtRS Marker Gene Expression {#sec2.5}
--------------------------------------------------------------------------------------------------------

In compliance with increased caffeine-induced Ca^2+^ release in cells with mitochondrial dysfunction in [Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}, *RyR3* mRNA and proteins were increased in CcO4KD C2C12 cells ([Figures 6](#fig6){ref-type="fig"}A and 6B) and both RyR1 and RyR3 proteins were induced in mtDNA-depleted HCT116 cells ([Figures 6](#fig6){ref-type="fig"}C and 6D). Notably, *IP3R* mRNA was not induced in CcO4KD cells. This is consistent with our previous report showing no increase in IP3R protein in mtDNA-depleted C2C12 cells ([@bib10]). As the RyR channels are known to be leaky ([@bib24]; [@bib43]), we reasoned that increased RyR expression may be the reason for increased cytosolic Ca^2+^ levels. To test this possibility, we silenced all three *RyR* mRNAs using shRNA targeted to the common conserved region among all three genes. [Figure 6](#fig6){ref-type="fig"}E shows the levels of shRNA KD of *RyR* genes in control and mtDNA-depleted C2C12 cells. Immunoblots in [Figure 6](#fig6){ref-type="fig"}E show that the RyR protein levels were markedly lower in mtDNA-depleted cells stably transduced with shRNA expression vectors than in control cells and cells transduced with a scrambled shRNA expression vector (top panel). Levels of IGF1R (second panel from the top) and matured cathepsin L protein (second panel from the bottom) were also reduced in cells expressing *RyR* shRNA. Both these proteins are important markers of MtRS ([@bib3], [@bib2]; [@bib10]; [@bib35]). Control cells with normal mtDNA levels with or without expression of shRNA for *RyR* mRNAs do not express these genes ([Figure 6](#fig6){ref-type="fig"}E). These results confirm that increased *RyR* expression is essential for the initiation and/or propagation of MtRS.Figure 6Role of RyR Ca^2+^ Channel Activation in Increased \[Ca^2+^\]~c~ in Response to Mitochondrial Stress(A) Real-Time PCR data on RyR and IP3R channel mRNA induction in CcO4KD C2C12 cells.(B) Immunoblot data showing the induction of RyR protein level in control, mtDNA-depleted, and CcO4KD C2C12 cells. 50 μg protein was loaded in each lane, and GAPDH was used as the loading control.(C) Immunoblot showing RyR1 and RyR3 induction in mtDNA-depleted HCT116 cells.(D) The qPCR data showing induction of RyR mRNA in mtDNA-depleted HCT116 cells.(E) Immunoblot analysis of proteins from control and mtDNA-depleted C2C12 cells expressing scrambled shRNA and two different RyR-specific shRNAs (named shRNA 1 or shRNA 2). Different molecular weight range areas of the same blot (∼500 kDa, ∼110 kDa, and about 40 kDa) were excised and probed with antibodies against RyR1, IGF1R, and cathepsin L proteins. GAPDH was used as a loading control.(F and G) The agonist induced Ca^2+^ release in (F) mtDNA-depleted and (G) mtDNA-depleted/RyR KD cells. Note that caffeine failed to induce Ca^2+^ release in mtDNA-depleted/RyR KD cells. Traces show the average response of three identical runs (average ≤ 30 cells/run) following the addition of different agonists in each cell line. Recorded data were further analyzed by SpectralyzerLSMDeluxe version 2009092525 software to subtract the background fluorescence before calculate the F~380/340~ ratio and finally represented as nM.(H) The steady-state \[Ca^2+^\]~c~ levels in mtDNA-depleted and mtDNA-depleted/RyR KD cells. Caff, caffeine; Ach, acetylcholine; Tg, thapsigargin.(I) Relative Cn activity in control, mtDNA-depleted C2C12 cells, and depleted cells expressing scrambled and specific shRNAs against all three RyR genes. Note that shRNA expression against RyR genes downregulated the activity. Mean ± SD was calculated from three independent experiments. Significance was calculated by one-way ANOVA with Tukey\'s multiple-comparison test, and data are presented as mitochondrial dysfunctional group versus control. In all experiments error bars represent standard deviations (∗p \< 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001).

To ascertain the role of RyR channel activity in the induced expression of MtRS target genes, we measured agonist-induced Ca^2+^ release in RyR KD C2C12 cells. [Figures 6](#fig6){ref-type="fig"}F and 6G show the agonist-induced Ca^2+^ release patterns in mtDNA-depleted ([Figure 6](#fig6){ref-type="fig"}F) and mtDNA-depleted/RyR KD ([Figure 6](#fig6){ref-type="fig"}G) C2C12 cells. RyR KD eliminated caffeine-mediated Ca^2+^ release in mtDNA-depleted cells. Notably, the basal \[Ca^2+^\]~c~ level was reduced to ∼38 nM in RyR KD cells from ∼90 nM in mtDNA-depleted cells ([Figure 6](#fig6){ref-type="fig"}H). Consistent with the reduced \[Ca^2+^\]~c~, Cn activity was also reduced to control cell levels in mtDNA-depleted/RyR KD cells ([Figure 6](#fig6){ref-type="fig"}I). These results together show that induced activation of the RyR channel is a critical factor in the activation of Cn and downstream signaling cascade.

To further ascertain the role of induced or activated RyR Ca^2+^ channel in inducing Cn activation and MtRS, which in turn induces cell proliferation and invasive behavior ([@bib20]; [@bib49]), we tested the effects of RyR channel KD in C2C12 cells in a scratch test ([Figure S4](#mmc1){ref-type="supplementary-material"}) and the effects of RyR channel blocking with 50 μM ryanodine in C2C12 cells by Matrigel invasion ([Figure 7](#fig7){ref-type="fig"}A). Results show that KD of all three *RyR* mRNAs markedly reduced the migration of mtDNA-depleted C2C12 cells in a scratch test ([Figure S4](#mmc1){ref-type="supplementary-material"}). This assay revealed that the original scratch area was reduced by about 20% in control cells, whereas in mtDNA-depleted cells it was reduced by about 83% of the area in 24 h. There was no change in scrambled shRNA-expressing cells when compared with mtDNA-depleted cells, whereas *RyR* mRNA KD cells showed a remarkable recovery close to the control cell level ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Similarly, mtDNA-depleted C2C12 cells showed nearly 2-fold higher Matrigel invasion, which was effectively reduced by treatment with 50 μM ryanodine, an RyR antagonist that showed a marked reduction in Matrigel invasion as shown in [Figures 7](#fig7){ref-type="fig"}A and 7B. We also used different concentrations of (5 and 10 μM) cell-permeable derivative of S107, which marginally reduced the invasion of cells through Matrigel. S107 is known to block the leaky intracellular calcium release by stabilizing FKBP12 and RyR associations. This treatment ([Figure 7](#fig7){ref-type="fig"}A, last two panels) significantly reduced the number of invasive cells compared with the mtDNA-depleted C2C12 cells. We further assessed the levels of FKBP12 association with RyR proteins by immunoprecipitation ([Figure 7](#fig7){ref-type="fig"}C). We found a marked increase in RyR protein in the immunoprecipitate and a considerably lower level of FKBP12 protein compared with that found in control cells. It has been reported that 1:1 stoichiometry of RyR and FKBP protein subunit, i.e., 4:4 is necessary for efficient regulation of tetrameric RyR channels ([@bib15]; [@bib44]). In light of this, our results confirm that stress-induced RyR channels are leaky and responsible for increased \[Ca^2+^\]~c~, which is a critical factor in MtRS.Figure 7Effects of RyR Channel Antagonists and Stabilizers on the Invasive Property of mtDNA-Depleted C2C12 CellsRyanodine, an antagonist of RyR channels, and S107, an effective stabilizer of RyR1 and FKBP association, were used.(A) Top panel: Matrigel invasion of control C2C12 cells treated with or without 50 μM ryanodine for 16 h before cells were loaded in the chamber. Lower panel: *In vitro* Matrigel invasion of mtDNA-depleted C2C12 cells treated with or without 50 μM ryanodine or different concentrations of RyR-FKBP stabilizer S107. Scale bars, 100 μM.(B) Quantitation of invading cells from three separate experiments. The significance was calculated by one-way ANOVA with Tukey\'s multiple-comparison test, and data are presented as the treatment group versus no-treatment control. In all experiments error bars represent standard deviations (∗p \< 0.05, ∗∗∗∗p ≤ 0.001).(C) Immunoblot analysis (n = 3) of FKBP proteins coimmunoprecipitated with RyR from control and mtDNA-depleted C2C12 cells. The total lysate (Input) and immunoprecipitated proteins were probed with antibody to RyR and FKBP 12. IB, immunoblotting; IP, immunoprecipitation.

Discussion {#sec3}
==========

Multiple mechanisms of mitochondria to nucleus cross talk have been described to explain changes in nuclear gene expression in response to mitochondrial genetic or metabolic defects ([@bib16]; [@bib54]). These include Ca^2+^/Cn activation, mitochondrial unfolded protein response, mitochondrial reactive oxygen species-induced HIF1α or MAP kinase activation, and activation of microRNA ([@bib16]; [@bib17]; [@bib33]). In previous studies, we showed that partial mtDNA depletion by chemical treatment of ethidium bromide or ddC caused a steady and sustained increase in the cytoplasmic Ca^2+^, which in turn caused activation of protein phosphatase, Cn ([@bib3]; [@bib10], [@bib12]). In some cells, Cn activation occurred at the transcription level by inducing the expression of *Cn Aα* mRNA, whereas in other cells, the activation was mostly post-translational through Ca^2+^/calmodulin binding without a significant increase in transcription ([@bib41]). This signaling cascade induced the expression of \>120 nuclear genes involved in an array of cellular processes including plasma membrane receptors, cell cycle regulators, cytoskeletal proteins, and proteins associated with mitochondrial oxidative metabolism ([@bib12]). We also showed that in immortalized cells, MtRS induced changes in cell morphology and invasive behavior, typical of tumor cells ([@bib11]; [@bib49]). In this study, we elucidated the mechanism of altered Ca^2+^ homeostasis in cells subjected to mitochondrial stress using partial mtDNA depletion and also *CcO* subunit *IVi1* mRNA silencing (CcO4KD) as stress inducers in two different cell lines. Our results show that a combination of altered uniporter function and markedly increased RyR Ca^2+^ channel activity in response to mitochondrial stress together contribute to increased cytoplasmic Ca^2+^ levels.

Mitochondria play a critical role in the regulation of cellular Ca^2+^ homeostasis, mainly by acting as an important storage compartment ([@bib5]). The MCUC has been shown to be the main system for the transport of Ca^2+^ released from IP3 and other channels in response to agonist-induced activation ([@bib51]). We examined the MCUC components, and MCU was consistently downregulated in both cell types in response to mitochondrial stress. This is consistent with impaired Ca^2+^ clearance by mitochondria from stressed cells. However, KD of *MCU* alone did not induce MtRS markers, suggesting the need for other factors in inducing MtRS.

In extension of our previous observations in mtDNA-depleted C2C12 cells and A549 lung carcinoma cells ([@bib3]; [@bib10]), we observed marked variations in the activity of RyR channels versus IP3R channels in cells with dysfunctional mitochondria. In control cells, there were high levels of Ca^2+^ release in response to IP3 channel agonist acetylcholine, but no detectable Ca^2+^ release in response to RyR channel agonist caffeine. In CcO4KD cells and mtDNA-depleted HCT116 cells, there was a marked reduction in acetylcholine-invoked Ca^2+^ release, whereas caffeine invoked a 5- to 10-fold higher Ca^2+^ release, suggesting a dramatic change in the inducibility or activity of these two channels. The overall Ca^2+^ pool that is released from the ER in the control and CcO4KD cells appears to be similar as seen from the total Ca^2+^ release invoked by ATP. Although the precise reason for this change in response to mitochondrial dysfunction remains unclear, it is most likely related to changes in the regulation of channels and also in the steady-state protein levels. We observed a large increase in RyR channel protein level and a corresponding increase in mRNA levels in response to the mitochondrial membrane or DNA damage. Similar patterns of *RyR* mRNA and protein increase, as well as a large increase in caffeine-evoked Ca^2+^ release, are observed in response to mitochondrial respiratory and metabolic inhibitors, including FCCP, antimycin A, oligomycin, and hypoxia ([@bib10], [@bib13]; [@bib48]). Our results show that increased expression and altered activation of RyR Ca^2+^ channels is a hallmark of mitochondrial dysfunction. Notably, IP3R-evoked Ca^2+^ release is markedly reduced in cells with mitochondrial stress.

The three isoforms of RyR receptor Ca^2+^ channels RyR1, RyR2, and RyR3 show nearly 70% homology in terms of amino acid sequences and are expressed in a cell- and tissue-specific manner. In C2C12 myocytes mostly RyR1 and RyR2 are expressed, whereas RyR3 is predominantly expressed in HCT116 colon cancer cells. RyR channel dysfunction or dysregulation has been implicated in many musculoskeletal disorders, and myocardial diseases associated with many mutations in RYR genes have been reported ([@bib8]). RyR channels are tightly regulated by binding of tetrameric FK binding proteins 12.0 to the partially opened tetrameric receptor complex ([@bib1]). In the striated muscle cells, RyR channels are tightly regulated by binding to FKBP proteins in a stoichiometric ratio. The complex is destabilized by FKBP dissociation, implicating Ca^2+^ mishandling, which is associated with cardiac and skeletal myopathies ([@bib7]; [@bib19]).

Protein kinase A (PKA)-mediated phosphorylation of channel proteins reduces the affinity of the tetrameric complex for binding to FKBP tetramers thus causing a dysregulated or "leaky" channel ([@bib1]; [@bib24]; [@bib39]; [@bib43]). Our results show that the steady-state levels of both FKBP 12.0 proteins are markedly reduced ([Figure S5](#mmc1){ref-type="supplementary-material"}) in cells with mitochondrial dysfunction. Based on this, we propose that a combination of increased RyR channel proteins and reduction of regulatory FKBP subunits results in the assembly of leaky channels, which result in increased \[Ca^2+^\]~c~. The possible involvement of RyR Ca^2+^ channel function was further tested in two ways: first, RyR channel mRNA KD in mtDNA-depleted cells aborted the expression of MtRS markers including *Cn*, *IGF1R,* and *cathepsin L*. Furthermore, *RyR* mRNA KD also reduced the invasive potential of mtDNA-depleted C2C12 cells as tested by wound healing assay ([Figure S4](#mmc1){ref-type="supplementary-material"}). In the second approach, the use of ryanodine, a specific antagonist of the RyR channel, essentially abrogated the increase in \[Ca^2+^\]~c~ (data not shown), activation of Cn, and the invasive property of mtDNA-depleted C2C12 cells. We, therefore, provide direct and rigorous proof for the involvement of activated RyR Ca^2+^ channels in inducing MtRS.

Results presented here also show that mitochondrial Ca^2+^ clearance is severely curtailed in cells with mitochondrial dysfunction (mtDNA depletion or CcO subunit KD). It is noteworthy that dysfunctional mitochondria also showed lower levels of mitochondrial uniporter protein MCU, although other members of uniporter complex such as MICU1 and EMRE are affected in a variable, cell-specific manner. In this regard, cells with mitochondrial defect show impaired uniporter complex and altered Ca^2+^ clearance as shown by Mootha\'s group by shRNA-mediated KD of *MCU1* uniporter protein ([@bib9]; [@bib40]). Taken together, the results of this study provide mechanistic details of MtRS with respect to altered Ca^2+^ release from ER and altered Ca^2+^ clearance from mitochondria as the basis of Cn activation at the point of initiation of MtRS.

Limitations of the Study {#sec3.1}
------------------------

Although we present evidence for the upregulation of MtRS marker genes in both MCU1-depleted and MCU1-deleted mtDNA-depleted cells, a more comprehensive proteomic analysis and gene expression analyses would have been more informative. We plan to carry out these analyses in our future experiments. The FKBP binding to tetrameric RyR channel protein can be affected either by reduced steady-state levels of FKBP proteins or PKA-mediated phosphorylation of RyR channel proteins. Based on lower steady-state levels of FKBP, we suggested the former possibility. However, we cannot exclude the possibility of RyR subunit phosphorylation, which may also be the reason for the reduced affinity for the FKBP12, and this needs to be investigated. The Ca^2+^ leak or mishandling due to dysregulation of RyR channels has been well documented in cardiac and skeletal myopathies, as discussed earlier in the article. In this respect, it would be interesting to study the possible activation of MtRS and its role in these muscle disease models.
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